Evidence map›Paper›PMID 41568240›Full record

ArticleHemaSphere2026

Clinical impact of immunoglobulin heavy chain repertoire in mantle cell lymphoma: A study from the Fondazione Italiana Linfomi (FIL) Phase III MCL0208 trial.

Simone Ragaini, Elisa Genuardi, Beatrice Alessandria, Aurora Maria Civita, Andrea Evangelista, Daniela Drandi, Carlotta Montana, Sofia Russo, Chiara Consoli, Mariapia Pironti and 14 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Simone RagainiDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.ORCID https://orcid.org/0000-0003-3899-5755
Elisa GenuardiDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.
Beatrice AlessandriaDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.
Aurora Maria CivitaDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.
Andrea EvangelistaUnit of Clinical Epidemiology Azienda Ospedaliera Universitaria Città della Salute e della Scienza and CPO Piemonte Torino Italy.
Daniela DrandiDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.
Carlotta MontanaDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.
Sofia RussoDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.
Chiara ConsoliDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.
Mariapia PirontiDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.
Stefan HohausDipartimento di Scienze di laboratorio ed ematologiche, Radioterapia Oncologica ed Ematologia Fondazione Policlinico Universitario A. Gemelli, IRCCS Rome Italy.
Gerardo MusuracaIRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Hematology Unit Meldola Italy.
Nicola CascavillaIRCCS, Casa Sollievo della Sofferenza Hematology Division San Giovanni Rotondo Italy.
Chiara GhiggiIRCCS San Martino U.O. Ematologia e Terapie cellulari Genova Italy.
Monica TaniUOC. Ospedale Santa Maria delle Croci, Hematology Unit Ravenna Italy.
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine University of Eastern Piedmont Novara Italy.
Jacopo OlivieriCentro trapianti e terapie cellulari, Clinica ematologica Ospedale Santa Maria della Misericordia- ASUFC Udine Italy.
Sara V UsaiOspedale Oncologico Armando Businco Division of Hematology Cagliari Italy.
Nicola Di RenzoVito Fazzi Hospital Unit of Hematology Lecce Italy.
Mario LuppiHematology Unit, AOU of Modena and Department of Medical and Surgical Sciences University of Modena and Reggio Emilia Modena Italy.
Vittorio StefoniIRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli", Bologna Bologna Italy.
Federica CavalloDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.ORCID https://orcid.org/0000-0003-2047-1099
Marco LadettoDivision of Hematology, Department of Translational Medicine University of Eastern Piedmont Novara Italy.
Simone FerreroDepartment of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino and Città della Salute e della Scienza di Torino Torino Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41568240
PMCPMC12816975

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.